AlphaMadera's AlphaVal page classifies Enova International, Inc. as a Banks, Insurers & Asset Managers business and values it using P/Tangible Book × ROE Quality, then compares the result to the current market price to flag ENVA as undervalued, fairly valued, or overvalued.

What is Enova International, Inc.'s fair value?

Fair value for ENVA comes from a P/Tangible Book × ROE Quality model -- the approach AlphaVal selected for this company's Banks, Insurers & Asset Managers classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value ENVA?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. ENVA was classified as Banks, Insurers & Asset Managers and is valued using P/Tangible Book × ROE Quality, built from ENVA's most recent reported fundamentals.

ENVA - Enova International, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $246.60 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 80% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Overvalued Mild

Trading 10.7% above fair value

Current Price $182.59

Bear Case $115.44 36.8% downside ($115.44 - $182.59) / $182.59 = -36.8% ROTCE 20.0% → 2.17x TBV

Fair Value $164.91 9.7% downside ($164.91 - $182.59) / $182.59 = -9.7% ROTCE 25.0% → 2.85x TBV

Bull Case $214.39 17.4% upside ($214.39 - $182.59) / $182.59 = 17.4% ROTCE 30.0% → 3.53x TBV

Adjust Assumptions

Return on Tangible Equity

29.3%

Cost of Equity

11.4%

Key Value Driver

ROTCE (29.3%) vs. cost of equity (11.4%)

Terminal Value % of EV

Implied Market Multiple 4.31x

Market is pricing in (growth)

Plain-Language Summary

With ROTCE of 29.3% vs. 11.4% cost of equity, fair P/TBV is 2.85x on $42.32 tangible book, implying $164.91 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (10 analysts) $246.60

Analyst Range $200.00 – $283.00

Divergence from AlphaVal 33%

Warnings

⚠ Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.

⚠ Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.

ℹ Wall Street's average price target is $246.60 (from 10 analysts). Our estimate is 33% below the consensus -- consider that gap carefully.

Key Risks

Book value quality matters as much as level — check loan loss reserves
Interest rate sensitivity creates non-linear earnings surprises
Insurance reserving is actuarial, not financial — errors emerge slowly